Evaluation of early medication persistence with omidenepag isopropyl, a topical selective prostaglandin EP2 agonist, in patients with glaucoma: a retrospective two-institute study.
Shunsuke NakakuraAkiyasu KanamoriYasuko FukumaSeita WakabayashiYuki NagataMiku AdachiPublished in: BMJ open (2021)
Medication persistence with omidenepag isopropyl is mostly positive; however, clinicians should also be cautious of early failure.